MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-POSITIVE CRESCENTIC GLOMERULONEPHRITIS COMPLICATING THE COURSE OF GRAVES-DISEASE - REPORT OF 3 ADULT CASES

被引:63
作者
TANEMOTO, M
MIYAKAWA, H
HANAI, J
YAGO, M
KITAOKA, M
UCHIDA, S
机构
[1] TEIKYO UNIV,SCH MED,DEPT INTERNAL MED 1,DIV NEPHROL,ITABASHI KU,TOKYO 173,JAPAN
[2] SHOWA GEN HOSP,DIV NEPHROL,TOKYO,JAPAN
[3] SHOWA GEN HOSP,DIV ENDOCRINOL,TOKYO,JAPAN
关键词
GRAVES DISEASE; PROPYLTHIOURACIL; CRESCENTIC GLOMERULONEPHRITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODY;
D O I
10.1016/0272-6386(95)90441-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has been recently recognized in Graves' disease patients treated with propylthiouracil. We have experienced three adult cases of Graves' disease with main features being renal derangements, All three patients, who were between the ages of 22 and 82 years, had been treated with propylthiouracil for 2 to 5 years after a diagnosis of Graves' disease. After several weeks of upper respiratory tract infection or flu-like symptoms, they abruptly began to manifest proteinuria and hematuria concomitant with severe anemia. Their serum creatinine increased from normal levels to 1.2 to 3.6 mg/dL. Renal biopsy revealed crescentic glomerulonephritis without deposition of immune complexes (ie, pauci-immune type). Crescent formations were observed in 40% to 60% of the glomeruli in al three cases, The serum from the patients revealed positive perinuclear-ANCA and negative cytoplasmic-ANCA (C-ANCA) pattern, and myeloperoxidase (MPO)-ANCA titers were 120 to 502 ELISA Units/mL (normal, < 10 ELISA Units/mL). A withdrawal of propylthiouracil with or without immunosuppressive therapy ameliorated their renal derangements. Graves' disease patients should be placed under vigilant observation by monitoring their urinalysis and serum creatinine, especially when being treated with antithyroid drugs and when suffering from flu-like symptoms. (C) 1995 by the National Kidney Foundation, Inc.
引用
收藏
页码:774 / 780
页数:7
相关论文
共 8 条
[1]  
COHENTERVAERT JW, 1990, KIDNEY INT, V37, P799
[2]   ANTITHYROID DRUGS [J].
COOPER, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) :1353-1362
[3]   VASCULITIS AND ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES ASSOCIATED WITH PROPYLTHIOURACIL THERAPY [J].
DOLMAN, KM ;
GANS, ROB ;
VERVAAT, TJ ;
ZEVENBERGEN, G ;
MAINGAY, D ;
NIKKELS, RE ;
DONKER, AJM ;
BORNE, AEGKV ;
GOLDSCHMEDING, R .
LANCET, 1993, 342 (8872) :651-652
[4]   ANCA-ASSOCIATED RENAL-DISEASE [J].
FALK, RJ ;
MCCLUSKEY, RT ;
KASSIRER, JP ;
MADIAS, NE ;
NILES, JL ;
KURTIN, P ;
NARAYAN, G ;
LEVEY, AS ;
RABSON, A ;
MADAIO, MP ;
PERRONE, RD ;
VLAKAHOS, DV ;
HARRINGTON, JT .
KIDNEY INTERNATIONAL, 1990, 38 (05) :998-1010
[5]  
HAAPALA AM, 1993, ADV EXP MED BIOL, V336, P81
[6]   PROPYLTHIOURACIL-INDUCED DIFFUSE INTERSTITIAL PNEUMONITIS [J].
MIYAZONO, K ;
OKAZAKI, T ;
UCHIDA, S ;
TOTSUKA, Y ;
MATSUMOTO, T ;
OGATA, E ;
TERAKAWA, K ;
KURIHARA, N ;
TAKEDA, T .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (09) :1764-1765
[7]   ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY-POSITIVE CRESCENTIC GLOMERULONEPHRITIS AS A COMPLICATION OF TREATMENT WITH PROPYLTHIOURACIL IN CHILDREN [J].
VOGT, BA ;
KIM, YK ;
JENNETTE, JC ;
FALK, RJ ;
BURKE, BA ;
SINAIKO, A .
JOURNAL OF PEDIATRICS, 1994, 124 (06) :986-988
[8]   THYROID SUPPRESSION TEST AND OUTCOME OF HYPER-THYROIDISM TREATED WITH ANTI-THYROID DRUGS AND TRIIODOTHYRONINE [J].
YAMAMOTO, M ;
IGARASHI, T ;
KIMURA, S ;
TSUKAMOTO, S ;
TOGAWA, K ;
OGATA, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (01) :72-77